Rituximab Trial for Pediatric Nephrotic Syndrome
NCT01716442
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
88
Enrollment
OTHER
Sponsor class
Conditions
Steroid Resistant Nephrotic Syndrome
Steroid Dependent Nephrotic Syndrome
Interventions
DRUG:
Rituximab
DRUG:
Placebo
Sponsor
Seoul National University Childrens Hospital